Thursday, March 28, 2024

Tag: Fast Track Designation

ReNetX Bio Receives Fast Track Designation From U.S. FDA

Potential First-in-Class Therapy for Chronic Spinal Cord Injury NEW HAVEN, Conn., Jan. 08, 2020 (GLOBE NEWSWIRE) -- ReNetX Bio announced today that the U.S. Food and Drug...